Sandbox Reserved 1502: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | <scene name='80/802676/Site_of_interaction/1'>Text To Be Displayed</scene>{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
=='''3lpt - HIV integrase'''== | =='''3lpt - HIV integrase'''== | ||
Line 43: | Line 43: | ||
====Structure and interaction with the antiviral==== | ====Structure and interaction with the antiviral==== | ||
The new experimental antirviral, here the (6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)acetic acid, interacts with | The new experimental antirviral, here the (6-chloro-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)acetic acid, interacts with <scene name='80/802676/Site_of_interaction/1'>the site which bind to the LEDGF/p75 cofactor</scene>. This site is situated in the core domain. | ||
The molecule | The molecule | ||